Epigenetic inactivation of calcium-sensing receptor in colorectal carcinogenesis

Modern Pathology

Volumn 24, Issue 6, 2011, Pages 876-884

  Hizaki, Keiichi ^a   Yamamoto, Hiroyuki ^a   Taniguchi, Hiroaki ^a   Adachi, Yasushi ^a   Nakazawa, Mayumi ^a   Tanuma, Tokuma ^a   Kato, Norihiro ^a   Sukawa, Yasutaka ^a   Sanchez, Jose V ^b   Suzuki, Hiromu ^a   Sasaki, Shigeru ^a   Imai, Kohzoh ^c   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

calcium sensing receptor; chemoprevention; colorectal adenoma; colorectal carcinogenesis; DNA methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; BISULFITE; CALCIUM SENSING RECEPTOR; FLUOROURACIL; MESSENGER RNA; TRICHOSTATIN A;

ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ADENOCARCINOMA; ADENOMA; ANTINEOPLASTIC AGENTS, ALKYLATING; AZACITIDINE; CACO-2 CELLS; CELL SURVIVAL; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; GENE EXPRESSION; GENE SILENCING; HUMANS; HYDROXAMIC ACIDS; RECEPTORS, CALCIUM-SENSING; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 79957904432     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.10     Document Type: Article

References (31)

1. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-2460.
2. Imai K, Yamamoto H. Carcinogenesis and microsatel-lite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008;29:673-680. (Pubitemid 351494153)
3. Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009;8:102-114.
4. Lipkin M. Preclinical and early human studies of calcium and colon cancer prevention. Ann N Y Acad Sci 1999;889:120-127. (Pubitemid 30040431)
5. Wargovich MJ, Jimenez A, McKee K, et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 2000;21:1149-1155. (Pubitemid 30389340)
6. Hhebert SC, Brown EM. The extracellular calcium receptor. Curr Opin Cell Biol 1995;7:484-492.
7. McNeil SE, Hobson SA, Nipper V, et al. Functional calcium-sensing receptors in rat fibroblasts are required for activation of src kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998;273:1114-1120. (Pubitemid 28049212)
8. Rutten MJ, Bacon KD, Marlink KL, et al. Identification of a functional Ca2+-sensing receptor in normal human gastric mucous epithelial cells. Am J Physiol 1999;277:G662-G670. (Pubitemid 29458240)
9. Geibel JP, Hebert SC. The functions and roles of the extracellular Ca2+-sensing receptor along the gastrointestinal tract. Annu Rev Physiol 2009;71:205-217.
10. Brown EM, Pollak M, Hebert SC. The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 1998;49:15-29. (Pubitemid 28197438)
11. Chakrabarty S, Radjendirane V, Appelman H, et al. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 2003;63:67-71. (Pubitemid 36070421)
12. 2+ and 1,25-dihydroxyvitamin D3. Cancer Res 2005;65:493-498.
13. Bhagavathula N, Kelley EA, Reddy M, et al. Upregula-tion of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. Br J Cancer 2005;93:1364-1371. (Pubitemid 41752863)
14. 2+ in colon carcinoma is dependent on calcium-sensing receptor expression and function. Int J Cancer 2007;121:1455-1462. (Pubitemid 47328703)
15. Liu G, Hu X, Varani J, et al. Calcium and calcium sensing receptor modulates the expression of thymi-dylate synthase, NAD(P)H:quinone oxidoreductase 1 and survivin in human colon carcinoma cells: promotion of cytotoxic response to mitomycin C and fluorouracil. Mol Carcinog 2009;48:202-211.
16. Saidak Z, Mentaverri R, Brown EM. The role of the calcium-sensing receptor in the development and progression of cancer. Endocr Rev 2009;30:178-195.
17. Whitfield JF. Calcium, calcium-sensing receptor and colon cancer. Cancer Lett 2009;275:9-16.
18. Ghevariya V, Anand S. A short primer on the calcium sensing receptor: an important cog in the colon cancer wheel? Dig Dis Sci 2011;56:279-284.
19. Rose MG, Farrell MP, Schmitz JC. Thymidylate synthase: a critical target for cancer chemotherapy. Clin Colorectal Cancer 2002;1:220-229. (Pubitemid 34269382)
20. Chu E, Callender MA, Farrell MP, et al. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside. Cancer Chemother Pharmacol 2003;52: S80-S89. (Pubitemid 37047028)
21. Liu G, Hu X, Chakrabarty S. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymi-dylate synthase and survivin and promotes cellular sensitivity to 5-FU. Int J Cancer 2010;126:631-639.
22. Sheinin Y, Kállay E, Wrba F, et al. Immunocytochem-ical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 2000;48: 595-602.
23. Li H, Myeroff L, Smiraglia D, et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci USA 2003;100:8412-8417. (Pubitemid 36842559)
24. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Fecal DNA vs fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714. (Pubitemid 39665324)
25. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastro-enterology 2005;129:422-428. (Pubitemid 41096630)
26. Taniguchi H, Yamamoto H, Hirata T, et al. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005;24: 7946-7952. (Pubitemid 41715201)
27. Taniguchi H, Yamamoto H, Akutsu N, et al. Transcrip-tional silencing of hedgehog interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer. J Pathol 2007;213: 131-139. (Pubitemid 47612235)
28. Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-107. (Pubitemid 29036293)
29. Maehata T, Taniguchi H, Yamamoto H, et al. Transcrip-tional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer. World J Gastroenterol 2008;14:2710-2722.
30. Takagi H, Sasaki S, Suzuki H, et al. Frequent epigenetic inactivation of SFRP genes in hepatocellu-lar carcinoma. J Gastroenterol 2008;43:378-389. (Pubitemid 351958902)
31. Hirata T, Yamamoto H, Taniguchi H, et al. Characterization of immune escape phenotype of human gastric cancers with and those without high-frequency micro-satellite instability. J Pathol 2007;211:516-523. (Pubitemid 46502427)